MedTrace Logo

Cohort of Patients With Rare Iron Overloads Excluding C282Y Homozygosity

NCT02619955 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2023-01-18

No results posted yet for this study

Summary

The study explores the hepcidin deficiency causes of rare iron overload (excluding C282Y homozygosity), and aim to characterize this iron overload in term of clinical, biological, genetic and functional spacificities.

Conditions

  • Rare Iron Overlaods

Interventions

OTHER

samples with DNA

Sponsors & Collaborators

  • Rennes University Hospital

    lead OTHER

Principal Investigators

  • Edouard BARDOU-JACQUET, MD/PhD · CHU Pontchaillou

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2023-01-31
Completion
2023-01-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02619955 on ClinicalTrials.gov